Skip to content

Comparison of Intravenous Ibuprofen And Intravenous Paracetamol In Reducing Migraine Headaches

Comparison of Intravenous Ibuprofen And Intravenous Paracetamol In Reducing Migraine Headaches

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017050333787N1
Enrollment
400
Registered
2017-10-05
Start date
2017-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine without aura [common migraine]

Interventions

Intervention 1: The intervention in the first group was 800 mg Ibuprofen and repeat if needed two hours later. Intervention 2: Intervention in the second group with ampoule of ?Acetaminophen 1000 mg a
Treatment - Drugs
The intervention in the first group was 800 mg Ibuprofen and repeat if needed two hours later
Intervention in the second group with ampoule of ?Acetaminophen 1000 mg and repeat if needed two hours later

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Migraine disease; Age range of 16-60 years; Absence of other neurological disorders; Non-addiction. Exclusion criteria: No neurological disorders; history of active peptic ulcer; pregnant women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The pain. Timepoint: Time zero and two hours later. Method of measurement: Visual analogue scale (vas).

Secondary

MeasureTime frame
Including stomach and intestinal ulcers and gastrointestinal bleeding. Timepoint: Two hours later. Method of measurement: Examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hossein Shaker

Iran University of Medical Sciences

drhshaker@yahoo.com-

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026